Costs of treatment and complications of adult type 1 diabetes

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 23, Issue 7, 2013, Pages 606-611

  Franciosi, M ^a   Lucisano, G ^a   Amoretti, R ^b   Capani, F ^c,d   Bruttomesso, D ^e   Di Bartolo, P ^f   Girelli, A ^g   Leonetti, F ^h   Morviducci, L ⁱ   Vitacolonna, E ^c,d   Nicolucci, A ^a  

^a Department of Clinical Pharmacology and Epidemiology Consorzio Mario Negri Sud ^*  (Italy)

^b SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d Online University Leonardo da Vinci   (Italy)

^e UNIVERSITY OF PADOVA   (Italy)

^f UO Diabetologia   (Italy)

^g Diabetes Unit   (Italy)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁱ SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Adult patients; Complication of diabetes; Cost analysis; Direct costs; Treatment costs; Type 1 diabetes

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BLOOD GLUCOSE MONITORING; CASE CONTROL STUDY; CHEMICAL ANALYSIS; CHRONIC KIDNEY DISEASE; COST; COST OF ILLNESS; DIABETIC ANGIOPATHY; DISEASE DURATION; DRUG COST; ECONOMICS; FEMALE; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE SURVEY; HOSPITALIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; INSULIN TREATMENT; ITALY; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MIDDLE AGED; MULTIVARIATE ANALYSIS; POISSON DISTRIBUTION; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; REVASCULARIZATION; UNIVARIATE ANALYSIS; YOUNG ADULT;

EID: 84884702741     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2012.03.002     Document Type: Article

References (17)

1. Amos A.F., McCarty D.J., Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997, 14(Suppl. 5):S7-S85.
2. Garattini L., Tediosi F., Chiaffarino F., Roggeri D., Parazzini F., Coscelli C., Gruppo di Studio Rilevazione Economica dei COsti e Risorse nel Diabete The outpatient cost of diabetes care in Italian diabetes centers. Value Health 2001, 4:251-257.
3. Tao B.T., Taylor D.G. Economics of type 1 diabetes. Endocrinol Metab Clin North Am 2010, 39:499-512.
4. Currie C.J., Poole C.D., Woehl A., Morgan C.L., Cawley S., Rousculp M.D., et al. The financial costs of healthcare treatment for people with type 1 or type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy. Diabet Med 2007, 24:187-194.
5. American Diabetes Association Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008, 31:596-615.
6. Dall T.M., Mann S.E., Zhang Y., Quick W.W., Seifert R.F., Martin J., et al. Distinguishing the economic costs associated with type 1 and type 2 diabetes. Popul Health Manag 2009, 12:103-110.
7. De Berardis G., D'Ettorre A., Graziano G., Lucisano G., Pellegrini F., Cammarota S., et al. The burden of hospitalization related to diabetes mellitus: a population-based study. Nutr Metab Cardiovasc Dis 2011 Feb 16, [Epub ahead of print].
8. Ying A.K., Lairson D.R., Giardino A.P., Bondy M.L., Zaheer I., Haymond M.W., et al. Predictors of direct costs of diabetes care in pediatric patients with type 1 diabetes. Pediatr Diabetes 2011, 12(3 Pt 1):177-182.
9. Govan L., Wu O., Briggs A., Colhoun H.M., McKnight J.A., Morris A.D., et al. Scottish Diabetes Research Network Epidemiology Group, Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish diabetes Research Network Epidemiology group. Diabetologia 2011, 54:2000-2008.
10. Johnson J.A., Pohar S.L., Majumdar S.R. Health care use and costs in the decade after identification of type 1 and type 2 diabetes: a population-based study. Diabetes Care 2006, 29:2403-2408.
11. Ballesta García M.J., Carral San Laureano F., Olveira Fuster G., Girón González J.A., Aguilar Diosdado M. Economics costsassociated to type 1 diabetes. Rev Clin Esp 2005, 205:523-527.
12. EQuality1 Study Group - Evaluation of QUALITY of Life and Costs in Diabetes Type 1, Nicolucci A., Maione A., Franciosi M., Amoretti R., Busetto E., et al. Quality of life and treatment satisfaction in adults with type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections. Diabet Med 2008, 25(2):213-220.
13. Franciosi M., Maione A., Pomili B., Amoretti R., Busetto E., Capani F., et al. Correlates of quality of life in adults with type 1 diabetes treated with continuous subcutaneous insulin injection. Nutr Metab Cardiovasc Dis 2010, 20:7-14.
14. Bruttomesso D., Filippi A., Costa S., Crazzolara D., Dal Pos M., Girelli A., et al. La terapia insulinica sottocutanea continua (CSII) in Italia. Seconda indagine nazionale. G It Diabetol Metab 2006, 26:110-116.
15. McCullagh P., Nelder J.A. Generalized linear models 1989, Chapman and Hall, London. 2nd ed.
16. Garattini L., Chiaffarino F., Cornago D., Coscelli C., Parazzini F., Study Group RECORD Rilevazione Economica del COsti e Risorse del Diabete Direct medical costs unequivocally related to diabetes in Italian specialized centers. Eur J Health Econ 2004, 5:15-21.
17. Annali AMD 2010 Indicatori di qualità dell'assistenza diabetologica in Italia 2010, Torino. Kino (Ed.).